ArticleOpen forum infectious diseases2023

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial.

Adrienne E Shapiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.